Integrating quantitative positron emission tomography (PET) and magnetic resonance imaging (MRI) to measure neuroinflammation

我们正在建立非侵入性成像方法，可以监测与身体对毒素，感染和损伤（也称为神经炎症）的免疫反应有关的大脑活动和结构的变化。神经炎症的关键特征包括：1）常驻神经炎症细胞（称为小胶质细胞）的活化，2）保护大脑免受血液中毒素影响的屏障（称为血脑屏障或BBB）的破坏，3）外周白色血细胞的浸润，以及4）神经炎症的后果，包括脑化学和结构的变化。激活的小胶质细胞可能是有益的，可以维持健康的脑细胞并清除不需要的入侵者，但长期的神经炎症可以减少大脑健康，通常在各种疾病中的脑组织损伤和认知症状之前，包括自身免疫性疾病，精神疾病，中风和痴呆症。因此，早期发现和治疗神经炎症将有利于加拿大人的长期大脑健康。为了更全面地评估神经炎症及其后果，需要将来自多种非侵入性成像方法的信息联合收割机的方法。这可以通过两种互补的成像技术来实现：磁共振成像（MRI）和正电子发射断层扫描（PET）。通过MRI，我们将通过对不同组织特征敏感的测量来检测神经炎症细胞，神经炎症期间过度表达的神经递质化学物质，以及BBB的破坏。通过PET，我们可以注射微量的放射性标记药物，直接靶向激活的小胶质细胞和突触密度（大脑健康的标志物）。这项NSERC发现资助的主要目标是开发和验证结合联合收割机和MRI测量神经炎症及其后果的方法。这些方法将使用神经炎症的男性和女性临床前模型和金标准组织分析进行验证，目的是开发一个综合成像平台，用于使用同步PET/MRI评估神经炎症。这项研究计划将为以下方面奠定基础：1）改善对健康和疾病中大脑的理解; 2）测试可能减缓或阻止疾病进展的治疗干预措施。重要的是，在拟议的成像研究计划和劳森健康研究所使用临床PET/MRI进行的人类大脑疾病的未来研究之间有一条明确的道路。一个整体的神经炎症成像平台将为脑部疾病患者带来更成功的诊断检查和治疗，减少重复就诊的需要，提高诊断效率。这反过来又将为所有加拿大人带来巨大的经济和社会利益。

We are building non-invasive imaging methods that can monitor changes in the activity and structure of the brain related to the body's immune response to toxins, infections, and injury (also known as neuroinflammation). Key features of neuroinflammation include: 1) activation of resident neuroinflammatory cells (known as microglia), 2) breakdown of the barrier that protects the brain from toxins in the blood (known as the blood-brain barrier or BBB) 3) infiltration of peripheral white blood cells, and 4) consequences of neuroinflammation, including changes in brain chemistry and structure. Activated microglia can be beneficial, maintaining healthy brain cells and removing unwanted invaders, but prolonged neuroinflammation can diminish brain health, often preceding brain tissue damage and cognitive symptoms in a wide variety of disorders, including autoimmune diseases, psychiatric disorders, stroke, and dementia. Because of this, early detection and treatment of neuroinflammation would be beneficial for the long-term brain health of Canadians. In order to get a more complete assessment of neuroinflammation and its consequences, approaches that combine information from multiple non-invasive imaging methods are needed. This can be accomplished with two complementary imaging technologies: magnetic resonance imaging (MRI) and positron emission tomography (PET). With MRI, we will detect neuroinflammatory cells with measurements sensitive to different tissue features, neurotransmitter chemicals that get overexpressed during neuroinflammation, and breakdown of the BBB. With PET, we can inject minute amounts of radiolabeled drugs that directly target activated microglia and synaptic density (a marker of brain health). The primary objective of this NSERC Discovery Grant will be to develop and validate methods that combine PET and MRI measures of neuroinflammation and its consequences. These methods will be validated using male and female preclinical models of neuroinflammation and gold standard tissue analysis, with the goal of developing a comprehensive imaging platform for assessing neuroinflammation using simultaneous PET/MRI. This research program will lay the groundwork for 1) improved understanding of the brain in health and disease and 2) testing therapeutic interventions that may slow or halt disease progression. Importantly, there is a clear path between the proposed imaging research program and future studies in human brain disease using the clinical PET/MRI at the Lawson Health Research Institute. A holistic neuroinflammation imaging platform will lead to more successful diagnostic exams and treatments in patients with brain disease, reducing the need for repeat visits and improving diagnostic efficacy. This, in turn, will have a substantial economic and societal benefit for all Canadians.